HCW Biologics Inc.
HCWB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 138.3% | 29.3% | -98.7% | – |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | -1,094.3% | 20% | 20% | 20% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -27,254.7% | -19,921.4% | -24,659.1% | -485.1% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -29,183.2% | -29,431% | -43,373.6% | -854.4% |
| EPS Diluted | -2.02 | -6.79 | -0.05 | -0.08 |
| % Growth | 70.3% | -13,480% | 37.5% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |